drugset / Trial / NCT05367232
A Study of ICP-033 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
A Dose finding Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Preliminary Anti-Tumor Activity of ICP-033 Tablets in Patients with Advanced Solid Tumors.
Timeline
- Start
- 2022-02-25
- Primary completion
- 2024-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ICP-033 | Unknown | — | Oral |
Indications
No indication recorded.